Skip to main content

Published

Early de novo T cell expansion following SARS-CoV-2 infection predicts favourable clinical and virological outcomes.
Fenn J. eBioMedicine 2025;:https://doi.org/10.1016/j.ebiom.2025.105795.
[The SARS-CoV-2 pandemic provided a unique opportunity to investigate de novo T cell-mediated protection in antigen-naïve individuals without the confounding effects of preexisting immune memory. These findings provide empiric evidence for early antigen-specific T cell expansion being protective against naturally acquired viral infection in humans.]
Freely available online

Age Groups
Adults
Conditions and Lifestyle Factors
Coronavirus Infections
Settings
Hospital Laboratories
Staff Groups
Microbiologist